Early research (Phase 1)Study completedNCT05853341
What this trial is testing
Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
Who this might be right for
Healthy
Luye Pharma Group Ltd. 48
Showing 20 of 61 results